The treatment of patients with MCTD depends on type of internal organ involvement, phase of the<unk> , and rate of<unk>  progression. Treatment strategies must follow conventional treatments that are used for similar problems in other rheumatic<unk> s (SLE, scleroderma, polymyositis). Usually the treatment of patients with MCTD include low doses of steroids, NSAIDs, immunosuppressive drugs, and biologic agents. The treatment options in refractory cases or in severe clinical conditions include immunoglobulins, cytotoxic agents, and biologic drugs.
Mixed connective tissue disease medical therapy
Undifferentiated connective tissue disease medical therapy
Scleroderma medical therapy
Juvenile idiopathic arthritis medical therapy
Mast cell tumor medical therapy
Churg-Strauss syndrome medical therapy
Goodpasture syndrome medical therapy
Wegeners granulomatosis medical therapy